Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

Actions
  • Price (USD)0.878
  • Today's Change0.002 / 0.23%
  • Shares traded5.23m
  • 1 Year change-8.35%
  • Beta0.2700
Data delayed at least 20 minutes, as of Apr 24 2024 16:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on $1000

1Y
Fund/benchmarkChange
PriceBioPharma Credit PLC (Ordinary Share)+4.58%
NAVBioPharma Credit PLC (Ordinary Share)+8.23%
Morningstar's BenchmarkNo benchmark--

Key statistics

On Wednesday, BioPharma Credit PLC (BPCR:LSE) closed at 0.878, 8.40% above its 52-week low of 0.81, set on Nov 09, 2023.
52-week range
Today
0.81Nov 09 20230.97Apr 24 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding1.23bn
Market cap1.08bn USD
Total assets1.21bn USD
Total expense ratio1.15%
High0.88
Low0.876
Previous close0.876
Average volume2.56m
YTD Change+4.52%
Beta0.2700
Diluted NAV (est)0.9848
Diluted NAV (last pub)0.98
Premium/Discount-10.84%
Net Gearing0.00%
Annual div (ADY)0.07
USD
Annual div yield (ADY)7.99%
Div ex-dateMar 28 2024
Div pay-dateApr 30 2024
Data delayed at least 20 minutes, as of Apr 24 2024 16:14 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.